Home/Filings/4/0001437749-16-043856
4//SEC Filing

Diffusion Pharmaceuticals Inc. 4

Accession 0001437749-16-043856

$CRVOCIK 0001053691operating

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 4:15 PM ET

Size

8.0 KB

Accession

0001437749-16-043856

Insider Transaction Report

Form 4
Period: 2016-12-27
Giles Mark T
Director
Transactions
  • Other

    Common Stock

    2016-12-27290,5800 total(indirect: By LLC)
  • Purchase

    Common Stock

    2016-12-28+290,580802,689 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By Trust)
    4,407
Footnotes (3)
  • [F1]In connection with certain personal investment, financial and tax planning strategies, (i) on December 27, 2016, PANDA Holdings, LLC ("PANDA"), of which the Reporting Person is the managing member, assigned 290,580 shares of the Issuer's common stock to an affiliate of PANDA for aggregate consideration of $1.00 and (ii) on December 28, 2016, such affiliate sold to MTG Investment Holdings, LLC ("MTGIH"), of which the Reporting Person is the sole member, 290,580 shares of the Issuer's common stock for aggregate consideration of $1.00.
  • [F2]The Reporting Person is the managing member of PANDA and may be deemed to be the beneficial owner of such securities. Mr. Giles disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F3]The Reporting Person is the sole member of MTGIH and may be deemed to be the beneficial owner of such securities. Mr. Giles disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001053691

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:15 PM ET
Size
8.0 KB